| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.11B | 8.83B | 7.94B | 6.58B | 5.43B | 4.80B |
| Gross Profit | 5.37B | 5.31B | 4.67B | 3.84B | 3.10B | 2.51B |
| EBITDA | 4.63B | 4.57B | 3.81B | 3.15B | 2.46B | 2.03B |
| Net Income | 1.97B | 2.07B | 1.71B | 1.30B | 866.00M | 680.00M |
Balance Sheet | ||||||
| Total Assets | 23.76B | 22.91B | 25.59B | 19.97B | 18.11B | 19.32B |
| Cash, Cash Equivalents and Short-Term Investments | 2.53B | 2.81B | 6.26B | 3.47B | 3.00B | 4.79B |
| Total Debt | 29.92B | 30.03B | 24.90B | 19.77B | 19.81B | 20.02B |
| Total Liabilities | 33.02B | 32.59B | 31.87B | 21.95B | 21.87B | 22.23B |
| Stockholders Equity | -9.27B | -9.69B | -6.29B | -1.98B | -3.77B | -2.92B |
Cash Flow | ||||||
| Free Cash Flow | 1.88B | 1.82B | 1.88B | 1.24B | 829.00M | 808.00M |
| Operating Cash Flow | 2.12B | 2.04B | 2.04B | 1.38B | 948.00M | 913.00M |
| Investing Cash Flow | -1.54B | -595.00M | -2.44B | -900.00M | -553.00M | -785.00M |
| Financing Cash Flow | -525.00M | -4.90B | 3.17B | -16.00M | -2.15B | -70.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $98.21B | 19.57 | 26.50% | 1.55% | -0.14% | 72.35% | |
75 Outperform | $65.25B | 47.45 | 8.28% | 1.61% | 2.83% | 47.00% | |
74 Outperform | $96.06B | 21.58 | 17.57% | 1.73% | 11.86% | 17.39% | |
74 Outperform | $144.34B | 22.26 | 80.53% | 2.77% | 2.88% | -35.15% | |
66 Neutral | $32.61B | 60.62 | 16.85% | 0.07% | 16.26% | 33.72% | |
65 Neutral | $65.05B | 49.35 | -26.55% | ― | 11.33% | 25.37% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |